Fluorescence signatures of SARS-CoV-2 spike S1 proteins and a human ACE-2: excitation-emission maps and fluorescence lifetimes.

Severe acute respiratory syndrome coronavirus 2 excitation-emission maps fluorescence fluorescence decay times human angiotensin-converting enzyme 2

Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
05 2022
Historique:
received: 20 12 2021
accepted: 12 04 2022
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

Fast and reliable detection of infectious SARS-CoV-2 virus loads is an important issue. Fluorescence spectroscopy is a sensitive tool to do so in clean environments. This presumes a comprehensive knowledge of fluorescence data. We aim at providing fully featured information on wavelength and time-dependent data of the fluorescence of the SARS-CoV-2 spike protein S1 subunit, its receptor-binding domain (RBD), and the human angiotensin-converting enzyme 2, especially with respect to possible optical detection schemes. Spectrally resolved excitation-emission maps of the involved proteins and measurements of fluorescence lifetimes were recorded for excitations from 220 to 295 nm. The fluorescence decay times were extracted by using a biexponential kinetic approach. The binding process in the SARS-CoV-2 RBD was likewise examined for spectroscopic changes. Distinct spectral features for each protein are pointed out in relevant spectra extracted from the excitation-emission maps. We also identify minor spectroscopic changes under the binding process. The decay times in the biexponential model are found to be   (  2.0  ±  0.1  )   ns and   (  8.6  ±  1.4  )    ns. Specific material data serve as an important background information for the design of optical detection and testing methods for SARS-CoV-2 loaded media.

Identifiants

pubmed: 35643871
pii: JBO-210386RR
doi: 10.1117/1.JBO.27.5.050501
pmc: PMC9142794
doi:

Substances chimiques

Membrane Glycoproteins 0
Spike Glycoprotein, Coronavirus 0
Viral Envelope Proteins 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Fluoresc. 2007 Mar;17(2):171-80
pubmed: 17265181
Scientometrics. 2020;125(3):2695-2726
pubmed: 32981988
Sci Rep. 2019 Aug 29;9(1):12598
pubmed: 31467322
Photochem Photobiol. 2004 Jul-Aug;80:41-6
pubmed: 15339207
Biosens Bioelectron. 2021 Apr 15;178:113004
pubmed: 33497877
Mol Cell Probes. 2020 Dec;54:101662
pubmed: 32911064
J Clin Virol. 2021 Feb;135:104713
pubmed: 33352470
J Fluoresc. 2007 Sep;17(5):455-9
pubmed: 17624580
PLoS One. 2013 Sep 30;8(9):e75270
pubmed: 24098687
Biotechnol Bioeng. 2019 Jun;116(6):1366-1379
pubmed: 30684365
Intervirology. 2015;58(5):318-23
pubmed: 26783743
Elife. 2020 Apr 02;9:
pubmed: 32228860
EBioMedicine. 2020 Sep;59:102903
pubmed: 32718896
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Biophys J. 1990 Feb;57(2):183-9
pubmed: 2180489
Sensors (Basel). 2020 Nov 18;20(22):
pubmed: 33218097
Nature. 2021 Feb;590(7845):202-205
pubmed: 33564189

Auteurs

Jonas Grzesiak (J)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Lea Fellner (L)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Karin Grünewald (K)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Christoph Kölbl (C)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Arne Walter (A)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Reinhold Horlacher (R)

Trenzyme GmbH, Konstanz, Germany.

Frank Duschek (F)

German Aerospace Center (DLR), Institute of Technical Physics, Hardthausen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH